News
There is growing outrage over the billions of expensive drugs being thrown away simply due to one-size-fits-all packaging.
Research
In this paper, we discuss the unique features of the market for anticancer drugs and assess trends in the launch prices for 58 anticancer drugs approved between 1995 and 2013 in the United States.
Journal of Economic Perspectives
December 1, 2015
Research
Dr. David Pfister of Memorial Sloan Kettering Cancer Center summarizes the work that Dr. Bach and colleagues regarding the high cost of cancer treatments and alternative pricing methods.
The Journal of Clinical Oncology
September 3, 2013